Description: Ventana Biotech, Inc. is a biotech company with a focus on identifying, evaluating, acquiring, developing and partnering to achieve commercialization of intellectual property in the area of drug candidates for personalized medicine. The Issuer has primarily targeted areas of anti-obesity and related illnesses.
1 Bachstrasse
Butschwil,
9606
Switzerland
Phone:
41 44 732 60 59
Officers
| Name | Title |
|---|---|
| Ms. Janne Christensen | Chief Exec. Officer, Pres, Chief Financial Officer, Treasurer and Director |
| Mr. David Holsworth | Chief Operating Officer, VP and Exec. Director |
| Ms. Marilyn Thom | VP of Admin. & HR |
| Mr. Elliott Martin | VP of Sales and Marketing |
| Mr. Trevor Conn | Exec. Director |
| Mr. Yoon Youngkeun | Sec. and Director |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 0 |